May 1, 2023
Today, FTLF Partner Adam J. Falcone will present at the National Council for Mental Wellbeing’s NatCon23. The conference runs from May 1-3 in Los Angeles, CA and is one of the largest [...]
April 18, 2023
Washington, DC — Feldesman Tucker Leifer Fidell LLP (FTLF), a nationally recognized law firm in health care, federal grant programs, and regulatory law, is excited to announce the opening of its new West [...]
April 18, 2023
Washington, DC — Feldesman Tucker Leifer Fidell LLP (FTLF) is delighted to announce that Kathryn E. Doi has joined the firm as a partner effective April 14, 2023 and will lead our [...]
April 14, 2023
On April 12, the Office for Civil Rights (OCR) issued a Notice of Proposed Rule Making (NPRM) to strengthen the federal privacy protections for reproductive health records. The NPRM seeks to address [...]
April 3, 2023
The month of March brought several significant new developments for the certified community behavioral health clinic (CCBHC) program. CCBHCs are outpatient safety-net behavioral health providers that, among a variety of program requirements, [...]
March 29, 2023
On February 17, 2023, the HHS Office for Civil Rights (OCR) released its Annual Report to Congress on Breaches of Unsecured Protected Health Information for Calendar Year 2021 (“HIPAA Breach Report”) and [...]
March 23, 2023
On March 8, 2023, the Health Resources and Services Administration (“HRSA”) updated its resource, Health Center Program FAQs, to include new and modified FAQs related to the Health Center Program, with a [...]
March 2, 2023
Next week, FTLF attorneys Martin Bree, Molly Evans, Matt Freedus, Susannah Vance Gopalan, Jason Reddish and Ted Waters will speak at the National Association of Community Health Centers’ (NACHC) Policy & Issues [...]
February 7, 2023
On February 3, 2023, the U.S. Department of Justice (DOJ) announced the withdrawal of three “outdated” health care antitrust policy statements that had been issued jointly by the DOJ and Federal Trade [...]
February 1, 2023
The United States Court of Appeals for the Third Circuit ruled on Monday in favor of drug manufacturers AstraZeneca, Sanofi and Novo Nordisk in their challenge against attempts by the Health Resources [...]